A random forest machine learning model outperformed traditional risk scores for predicting 6-month cardiovascular death or heart failure readmission after TAVR (AUC 0.791; 95% CI 0.766-0.816; P<0.001).
Observational (n=213)
Yes
Does a random forest-based machine learning model improve the prediction of 6-month outcomes and futility in high-risk patients undergoing TAVR compared to traditional risk scores?
A random forest machine learning model incorporating novel markers like lipid levels and pulse wave velocity significantly improves the prediction of 6-month TAVR futility compared to traditional risk scores.
Effect estimate: AUC 0.791 (95% CI 0.766-0.816)
p-value: p=<0.001
Background Transcatheter aortic valve replacement (TAVR) has broadened treatment for high-risk, inoperable patients with aortic stenosis, though existing risk models poorly predict its futility. Objective This study aimed to identify significant predictors of 6-month TAVR outcomes using interpretable machine learning to enhance risk stratification for TAVR futility. Methods We used a multicenter dataset of 213 patients (80.8 ± 5.8 years, 43.9% female). Two random forest-based machine learning models were developed to predict midterm outcomes: a primary outcome of cardiovascular death or heart failure readmission, and a secondary outcome that included cardiac functional and quality of life metrics. Model performance was evaluated using repeated 5-fold cross-validation, and top features were interpreted with SHapley Additive exPlanations. Results The random forest model outperformed traditional risk scores and a baseline logistic regression model for both outcomes ( P < .001), with AUCs of 0.791 (0.766-0.816) and 0.784 (0.764-0.804) for the primary and expanded outcomes, respectively. The analysis identified a panel of key predictors that included traditional risk scores alongside a set of novel markers. Lower low-density lipoprotein cholesterol, lower high-density lipoprotein cholesterol, and high carotid-femoral pulse wave velocity were predictive for both outcomes. Lower estimated glomerular filtration rate and low serum creatine phosphokinase were unique predictors for the primary and expanded outcomes, respectively. Conclusion Our findings highlight the need to shift TAVR risk prediction from a one-size-fits-all model to a personalized framework, offering a new lens for patient assessment and opportunities for targeted interventions to reduce futility and improve outcomes.
Sun et al. (Tue,) conducted a observational in Aortic stenosis (n=213). Random forest machine learning model vs. Traditional risk scores and logistic regression was evaluated on Cardiovascular death or heart failure readmission (AUC 0.791, 95% CI 0.766-0.816, p=<0.001). A random forest machine learning model outperformed traditional risk scores for predicting 6-month cardiovascular death or heart failure readmission after TAVR (AUC 0.791; 95% CI 0.766-0.816; P<0.001).